2031년까지의 아시아 태평양 생물공정 시장 전망 - 지역 분석 - 제품별(기기 및 소모품 및 액세서리), 운영 규모(상업 운영 및 임상 운영), 공정(하류 생물공정 및 상류 생물공정), 응용 분야(단일클론 항체, 백신, 재조합 단백질, 세포 및 유전자 치료 및 기타), 최종 사용자(생물제약 회사, 계약 제조 기관 및 기타)

BMIRE00030823 | Pages: 168 | Biotechnology | Oct 2024 | Type: Regional | Status: Published

아시아 태평양 생물공정 시장은 2023년에 5,488.87백만 달러 규모였으며 2031년까지 16,868.77백만 달러에 도달할 것으로 예상되며 2023년에서 2031년까지 15.1%의 CAGR을 기록할 것으로 추산됩니다.

개인화된 의학에 대한 급증하는 수요로 아시아 태평양 생물공정 시장이 활성화됨

의료 산업이 일률적인 접근 방식에서 타깃팅된 접근 방식으로 전환되면서 개인화된 의학에 대한 수요가 확대되고 있습니다. 정밀 의학은 암, 신경 퇴행성 질환, 희귀 유전적 질환과 같은 건강 문제를 해결하는 가장 유망한 접근 방식 중 하나로 여겨지고 있습니다. 개인화된 의약품 생산의 혁신은 전체 부문에 영향을 미칠 가능성이 높으며, 소량 생산을 목표로 하는 일회용 기술은 특히 하류 공정에서 단백질 생물 생산에 잠재적으로 적용될 수 있습니다. 개인화되고 차별화된 의학 접근 방식은 더 광범위한 제품에 대한 필요성으로 이어지고 있으며, 그 중 많은 제품이 비교적 소수의 환자를 대상으로 합니다. 따라서 생물학적 제품의 생산 및 제공에 대한 근본적으로 다른 접근 방식이 필요할 수 있습니다. 정밀 의학은 개인의 유전체 정보를 활용하여 특정 증상에 대한 표적 치료를 제공합니다. 희귀 질환의 증가로 인해 생물학제와 약물에 대한 수요가 증가했으며, 이로 인해 개인화된 의약품의 성장이 촉진되었습니다. 2019년 FDA는 질병의 근본 원인을 해결하고 정밀 의학을 임상 치료와 더욱 통합하기 위해 약 12개의 개인화된 약물을 승인했습니다. 또한 정부의 노력이 증가함에 따라 개인화된 의약품 연구 활동이 강화되고 있습니다. 예를 들어, 2020년 2월, 국립 인간 유전체 연구소(NHGRI)는 새로운 정밀 의학 및 유전체학 프로그램을 수립한다고 발표했습니다. 이 프로그램은 질병의 더 나은 진단 및 치료를 위한 유전체학 및 정보학 도구의 혁신에 중점을 둡니다. 개인화된 의약품은 유전학 및 생물정보학의 발전을 활용하여 특정 환자 집단을 표적으로 삼고 이전에는 치료할 수 없었던 질병을 치료합니다. 개인 맞춤 의학은 생물 처리 기술을 사용하여 맞춤형 치료법을 개발합니다. 특정 세포를 분리하는 것부터 환자 맞춤형 치료법을 개발하는 것까지, 생물 처리 단계는 각 환자에게 맞춤화된 치료법을 생산하는 데 필수적입니다. 따라서 개인 맞춤 의학에 대한 수요 증가는 예측 기간 동안 생물 처리 시장에서 활동하는 업체에 상당한 성장 기회를 제공할 것으로 예측됩니다.

아시아 태평양 생물 처리 시장 개요

아시아 태평양 생물 처리 시장은 중국, 일본, 인도, 한국, 호주 및 기타 아시아 태평양 지역으로 세분화됩니다. 이들 국가의 시장 성장은 만성 질환 유병률 증가와 유리한 환불 정책에 기인합니다. 또한 시장 참여자가 구현한 확장 및 제품 출시 전략은 이 지역의 생물 처리 기술 시장 성장에 기여할 것으로 예상됩니다. 중국은 2023년에 시장에서 가장 큰 점유율을 차지했으며 인도는 예측 기간 동안 시장에서 상당한 CAGR을 기록할 것으로 예상됩니다. 중국의 생물 제약 산업은 제네릭 중심 환경에서 번창하는 혁신 허브로 진화하면서 엄청난 변화를 겪고 있습니다. 또한, 산업화의 진전과 신약, 고급 의료 기기 및 기술의 적용은 중국의 생물 처리 시장 성장에 기여합니다. 따라서 연구 센터의 증가, 정부 자금 지원 증가, 시장 참여자가 지리적 확장을 위해 끊임없이 이니셔티브를 취하면서 아시아 태평양의 생물 처리 시장 성장이 촉진됩니다.

아시아 태평양 생물 처리 시장 수익 및 2031년 예측(백만 달러)

아시아 태평양 생물 처리 시장 세분화

아시아 태평양 생물 처리 시장은 제품, 운영 규모, 공정, 응용 프로그램, 최종 사용자 및 국가로 분류됩니다.

제품을 기준으로 아시아 태평양 생물 처리 시장은 기기와 소모품 및 액세서리로 나뉩니다. 기기 부문은 2023년에 더 큰 시장 점유율을 차지했습니다. 또한 기기 부문은 여과 장치, 생물 반응기, 크로마토그래피 시스템, 원심 분리기, 건조 장치 등으로 세분화됩니다. 또한, 생물 반응기 하위 세그먼트는 파일럿 규모, 풀 스케일 및 실험실 규모로 분류됩니다. 나아가, 하위 세그먼트 크로마토그래피 시스템은 액체 크로마토그래피, 가스 크로마토그래피 및 기타로 세분화됩니다. 또한, 소모품 및 액세서리 세그먼트는 시약, 세포 배양 배지, 크로마토그래피 수지 및 기타로 세분화됩니다.

운영 규모 측면에서 아시아 태평양 생물 처리 시장은 상업적 운영과 임상 운영으로 나뉩니다. 상업적 운영 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다.

프로세스 기준으로, 아시아 태평양 생물 처리 시장은 하류 생물 공정 및 상류 생물 공정으로 나뉩니다. 하류 생물 공정 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다.

응용 프로그램을 기준으로, 아시아 태평양 생물 처리 시장은 단일 클론 항체, 백신, 재조합 단백질, 세포 및 유전자 치료 및 기타로 분류됩니다. 단일클론 항체 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.

최종 사용자 측면에서 아시아 태평양 생물공정 시장은 생물제약 회사, 계약 제조 기관 및 기타로 분류됩니다. 생물제약 회사 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.

국가별로 아시아 태평양 생물공정 시장은 중국, 인도, 일본, 한국, 호주 및 기타 아시아 태평양 지역으로 세분화됩니다. 중국은 2023년에 아시아 태평양 생물공정 시장 점유율을 지배했습니다.

Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc 및 Cytiva US LLC는 아시아 태평양 생물공정 시장에서 운영되는 일부 선도 기업입니다.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Bioprocessing Market Landscape

4.1 Ecosystem Analysis

4.1.1 List of Vendors in the Value Chain

5. Asia Pacific Bioprocessing Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Chronic Diseases

5.1.2 Growing Biopharmaceutical Industry

5.2 Market Restraints

5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing

5.3 Market Opportunities

5.3.1 Proliferating Demand for Personalized Medicine

5.4 Future Trends

5.4.1 Shift Toward Automated Cell Therapy Manufacturing

5.5 Impact of Drivers and Restraints:

6. Bioprocessing Market - Asia Pacific Analysis

6.1 Asia Pacific Bioprocessing Market Overview

6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031

7. Asia Pacific Bioprocessing Market Analysis - by Product

7.1 Overview

7.2 Instruments

7.2.1 Overview

7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

7.3 Consumables & Accessories

7.3.1 Overview

7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

8. Asia Pacific Bioprocessing Market Analysis - by Scale of Operation

8.1 Overview

8.2 Commercial Operations

8.2.1 Overview

8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Clinical Operations

8.3.1 Overview

8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Bioprocessing Market Analysis - by Process

9.1 Overview

9.2 Downstream Bioprocess

9.2.1 Overview

9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Upstream Bioprocess

9.3.1 Overview

9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Bioprocessing Market Analysis - by Application

10.1 Overview

10.2 Monoclonal Antibodies

10.2.1 Overview

10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.3 Vaccines

10.3.1 Overview

10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.4 Recombinant Protein

10.4.1 Overview

10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.5 Cell & Gene Therapy

10.5.1 Overview

10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Asia Pacific Bioprocessing Market Analysis - by End User

11.1 Overview

11.2 Biopharmaceutical Companies

11.2.1 Overview

11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.3 Contract Manufacturing Organization

11.3.1 Overview

11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.4 Others

11.4.1 Overview

11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. Asia Pacific Bioprocessing Market - Country Analysis

12.1 Asia Pacific

12.1.1 Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

12.1.1.1 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.1.1 Overview

12.1.1.2 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.2.1 China: Bioprocessing Market Breakdown, by Product

12.1.1.2.1.1 China: Bioprocessing Market Breakdown, by Instruments

12.1.1.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.2.2 China: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.2.3 China: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.2.4 China: Bioprocessing Market Breakdown, by Process

12.1.1.2.5 China: Bioprocessing Market Breakdown, by Application

12.1.1.2.6 China: Bioprocessing Market Breakdown, by End User

12.1.1.3 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.3.1 Overview

12.1.1.4 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.4.1 India: Bioprocessing Market Breakdown, by Product

12.1.1.4.1.1 India: Bioprocessing Market Breakdown, by Instruments

12.1.1.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.4.1.2 India: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.4.2 India: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.4.3 India: Bioprocessing Market Breakdown, by Process

12.1.1.4.4 India: Bioprocessing Market Breakdown, by Application

12.1.1.4.5 India: Bioprocessing Market Breakdown, by End User

12.1.1.5 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.5.1 Overview

12.1.1.6 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.6.1 Japan: Bioprocessing Market Breakdown, by Product

12.1.1.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments

12.1.1.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.6.2 Japan: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.6.3 Japan: Bioprocessing Market Breakdown, by Process

12.1.1.6.4 Japan: Bioprocessing Market Breakdown, by Application

12.1.1.6.5 Japan: Bioprocessing Market Breakdown, by End User

12.1.1.7 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.7.1 Overview

12.1.1.8 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.8.1 South Korea: Bioprocessing Market Breakdown, by Product

12.1.1.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments

12.1.1.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.8.2 South Korea: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.8.3 South Korea: Bioprocessing Market Breakdown, by Process

12.1.1.8.4 South Korea: Bioprocessing Market Breakdown, by Application

12.1.1.8.5 South Korea: Bioprocessing Market Breakdown, by End User

12.1.1.9 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.9.1 Overview

12.1.1.10 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.10.1 Australia: Bioprocessing Market Breakdown, by Product

12.1.1.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments

12.1.1.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.10.2 Australia: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.10.3 Australia: Bioprocessing Market Breakdown, by Process

12.1.1.10.4 Australia: Bioprocessing Market Breakdown, by Application

12.1.1.10.5 Australia: Bioprocessing Market Breakdown, by End User

12.1.1.11 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.11.1 Overview

12.1.1.12 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product

12.1.1.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments

12.1.1.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process

12.1.1.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application

12.1.1.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Bioprocessing Market

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Getinge AB

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Thermo Fisher Scientific Inc

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Sartorius AG

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Corning Inc

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Bio-Rad Laboratories Inc

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Merck KGaA

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 3M Co

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Eppendorf SE

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Repligen Corp

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Entegris Inc

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Agilent Technologies Inc

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

14.12 Cytiva US LLC

14.12.1 Key Facts

14.12.2 Business Description

14.12.3 Products and Services

14.12.4 Financial Overview

14.12.5 SWOT Analysis

14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

 

 

?

List of Tables

Table 1. Asia Pacific Bioprocessing Market Segmentation

Table 2. List of Vendors

Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

Table 7. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 8. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 9. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 10. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 11. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 12. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 13. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 14. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 15. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 16. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 17. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 18. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 19. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 20. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 21. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 22. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 23. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 24. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 25. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 26. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 27. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 29. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 30. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 31. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 32. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 33. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 34. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 35. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 36. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 37. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 38. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 39. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 40. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 41. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 42. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 43. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 44. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 45. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 46. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 47. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 48. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 49. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 50. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 51. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 52. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 53. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 54. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 55. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 56. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 57. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 58. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 59. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 60. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market

Table 62. Recent Organic Growth Strategies in the Bioprocessing Market

Table 63. Glossary of Terms, Bioprocessing Market

 

?

List of Figures

Figure 1. Asia Pacific Bioprocessing Market Segmentation, by Country

Figure 2. Bioprocessing Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031

Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)

Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)

Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)

Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)

Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)

Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 24. Asia Pacific: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)

Figure 25. Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 26. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 29. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 30. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 31. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 32. Growth Strategies in the Bioprocessing Market

  1. Getinge AB
  2. Thermo Fisher Scientific Inc
  3. Sartorius AG
  4. Corning Inc
  5. Bio-Rad Laboratories Inc
  6. Merck KGaA
  7. 3M Co
  8. Eppendorf SE
  9. Repligen Corp
  10. Entegris Inc
  11. Agilent Technologies Inc
  12. Cytiva US LLC.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioprocessing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioprocessing market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2485
Site License
$4550
$3185
Enterprise License
$5550
$3885